Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription


1 AJR Am J Roentgenol
1 Am J Pathol
3 Biochem Biophys Res Commun
2 BMC Cancer
5 BMC Gastroenterol
1 Br J Surg
1 Cancer Res
2 Eur Radiol
1 Gut
2 Hepatology
1 Indian J Gastroenterol
1 J Gastroenterol Hepatol
4 J Hepatol
1 J Pediatr
1 PLoS One
1 Semin Liver Dis

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. CHEN Y, Xia Y, Tolat PP, Long L, et al
    Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    AJR Am J Roentgenol. 2021 Apr 7:1-11. doi: 10.2214/AJR.20.23255.
    PubMed         Abstract available

    Am J Pathol

  2. BAGLIERI J, Zhang C, Liang S, Liu X, et al
    Non-degradable collagen increases liver fibrosis but not hepatocellular carcinoma in mice.
    Am J Pathol. 2021 Jun 10. pii: S0002-9440(21)00254.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  3. ZENG Z, Shi Z, Liu Y, Zhao J, et al
    HIF-1alpha-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Biochem Biophys Res Commun. 2021;566:80-86.
    PubMed         Abstract available

  4. MA Y, Sun W, Zhang Q, Gao B, et al
    lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability.
    Biochem Biophys Res Commun. 2021;566:101-107.
    PubMed         Abstract available

  5. LI Y, Yi Q, Liao X, Han C, et al
    Hypomethylation-driven overexpression of HJURP promotes progression of hepatocellular carcinoma and is associated with poor prognosis.
    Biochem Biophys Res Commun. 2021;566:67-74.
    PubMed         Abstract available

    BMC Cancer

  6. LI X, Ye Z, Lin S, Pang H, et al
    Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
    BMC Cancer. 2021;21:701.
    PubMed         Abstract available

  7. CHEN C, Liu YQ, Qiu SX, Li Y, et al
    Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
    BMC Cancer. 2021;21:693.
    PubMed         Abstract available

    BMC Gastroenterol

  8. YEN FS, Lai JN, Wei JC, Chiu LT, et al
    Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
    BMC Gastroenterol. 2021;21:263.
    PubMed         Abstract available

  9. HUANG YT, Hsieh YY, Chen WM, Tung SY, et al
    Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan.
    BMC Gastroenterol. 2021;21:259.
    PubMed         Abstract available

  10. LU H, Zheng C, Liang B, Xiong B, et al
    Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis.
    BMC Gastroenterol. 2021;21:256.
    PubMed         Abstract available

  11. LEE HA, Goh HG, Lee YS, Jung YK, et al
    Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma.
    BMC Gastroenterol. 2021;21:258.
    PubMed         Abstract available

  12. AFSHARI A, Yaghobi R, Karimi MH, Mowla J, et al
    Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma.
    BMC Gastroenterol. 2021;21:262.
    PubMed         Abstract available

    Br J Surg

  13. WEI F
    Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2021 Jun 14. pii: 6298428. doi: 10.1093.

    Cancer Res

  14. SHRIKI A, Lanton T, Sonnenblick A, Levkovitch-Siany O, et al
    Multiple Roles of IL-6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis.
    Cancer Res. 2021 Jun 11. pii: 0008-5472.CAN-21-0321.
    PubMed         Abstract available

    Eur Radiol

  15. VICENTIN I, Mosconi C, Garanzini E, Sposito C, et al
    Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08088.
    PubMed         Abstract available

  16. YOON JH, Lee JM, Yu MH, Hur BY, et al
    Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08087.
    PubMed         Abstract available


  17. PARK H, Yoon EL, Cho S, Jun DW, et al
    Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease.
    Gut. 2021 Jun 14. pii: gutjnl-2021-325102. doi: 10.1136/gutjnl-2021-325102.


  18. SHI YF, Xie WZ
    Letter to the Editor: Risk Stratification in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
    Hepatology. 2021 Jun 15. doi: 10.1002/hep.32013.
    PubMed         Abstract available

  19. MAZUMDER NR, Simpson D, Atiemo K, Jackson K, et al
    Black Patients With Cirrhosis Have Higher Mortality and Lower Transplant Rates: Results From a Metropolitan Cohort Study.
    Hepatology. 2021 Jun 15. doi: 10.1002/hep.31742.
    PubMed         Abstract available

    Indian J Gastroenterol

  20. RATTANASUPAR A, Chang A, Akarapatima K, Chaojin T, et al
    Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial.
    Indian J Gastroenterol. 2021 Jun 15. pii: 10.1007/s12664-021-01150.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  21. PHRUEKSOTSAI S, Pinyopornpanish K, Euathrongchit J, Leerapun A, et al
    Dapagliflozin reduces hepatic and visceral fat in type-2 diabetes patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2021 Jun 15. doi: 10.1111/jgh.15580.
    PubMed         Abstract available

    J Hepatol

  22. WU J, Li H, Xu Z, Ran L, et al
    Population-specific cut-off points of fatty liver index for the diagnosis of hepatic steatosis.
    J Hepatol. 2021 Jun 9. pii: S0168-8278(21)00413.

  23. SELLAU J, Groneberg M, Hoenow S, Lotter H, et al
    The underlying cellular immune pathology of Entamoeba histolytica-induced hepatic amoebiasis.
    J Hepatol. 2021 Jun 11. pii: S0168-8278(21)00221.

  24. GEIDL-FLUECK B, Gerber PA
    Reply to Comments on "Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis - A randomized controlled trial".
    J Hepatol. 2021 Jun 12. pii: S0168-8278(21)00418.

  25. BOU SALEH M, Louvet A, Ntandja-Wandji LC, Boleslawski E, et al
    Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis.
    J Hepatol. 2021 Jun 12. pii: S0168-8278(21)00416.
    PubMed         Abstract available

    J Pediatr

  26. SUGA K, Suzue M, Nakagawa R, Ishibashi H, et al
    Neonatal Fever With Hepatomegaly and a Rapidly Involuting Congenital Hemangioma.
    J Pediatr. 2021 Jun 9. pii: S0022-3476(21)00519.

    PLoS One

  27. VAN AMERONGEN MJ, Vos AM, van der Woude W, Nagtegaal ID, et al
    Does perfusion computed tomography correlate to pathology in colorectal liver metastases?
    PLoS One. 2021;16:e0245764.
    PubMed         Abstract available

    Semin Liver Dis

  28. SU YY, Li CC, Lin YJ, Hsu C, et al
    Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives.
    Semin Liver Dis. 2021 Jun 15. doi: 10.1055/s-0041-1730949.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.